Effect of corticosteroids on course of Guillain-Barré syndrome

The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).

International journal of antimicrobial agents·2006

Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.

Expert opinion on investigational drugs·2005

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

The Journal of antimicrobial chemotherapy·1998

Empiric therapy in lower respiratory tract infection--an ongoing challenge.

Journal of chemotherapy (Florence, Italy)·1997

Tempting fate: control of communicable disease in England.

BMJ (Clinical research ed.)·1993

Safety of fleroxacin in clinical trials.

The American journal of medicine·1993

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Scleroderma Renal Crisis-Associated Thrombotic Microangiopathy Preceding Skin Sclerosis in Diffuse Cutaneous Systemic Sclerosis: A Case Report.

Internal medicine (Tokyo, Japan)·2026

Anakinra versus intramuscular methylprednisolone acetate for gout flares in people with chronic kidney disease (ASGARD): a UK randomised multicentre, double-blind, double-dummy controlled feasibility study with economic, qualitative and safety assessment.

BMJ open·2026

Korean College of Rheumatology treatment recommendations for patients with axial spondyloarthritis: 2026 update.

The Korean journal of internal medicine·2026

Magnetic resonance imaging: Clinical correlation in surgically treated isolated subacromial impingement syndrome.

Journal of medical imaging and radiation sciences·2026

Enrichment and Proteomic Profiling of Stromal-Associated Extracellular Vesicle Subpopulations From Arthritic Synovial Fluid by Size-Exclusion Chromatography Coupled to CD90-Directed Immunocapture.

Journal of extracellular vesicles·2026

Turkish Society for Rheumatology recommendations for topical and systemic treatments in Sjögren's disease.

Clinical and experimental rheumatology·2026

Related Experiment Videos

Effect of corticosteroids on course of Guillain-Barré syndrome

Related Concept Videos

The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).

Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

Empiric therapy in lower respiratory tract infection--an ongoing challenge.

Tempting fate: control of communicable disease in England.

Safety of fleroxacin in clinical trials.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Scleroderma Renal Crisis-Associated Thrombotic Microangiopathy Preceding Skin Sclerosis in Diffuse Cutaneous Systemic Sclerosis: A Case Report.

Anakinra versus intramuscular methylprednisolone acetate for gout flares in people with chronic kidney disease (ASGARD): a UK randomised multicentre, double-blind, double-dummy controlled feasibility study with economic, qualitative and safety assessment.

Korean College of Rheumatology treatment recommendations for patients with axial spondyloarthritis: 2026 update.

Magnetic resonance imaging: Clinical correlation in surgically treated isolated subacromial impingement syndrome.

Enrichment and Proteomic Profiling of Stromal-Associated Extracellular Vesicle Subpopulations From Arthritic Synovial Fluid by Size-Exclusion Chromatography Coupled to CD90-Directed Immunocapture.

Turkish Society for Rheumatology recommendations for topical and systemic treatments in Sjögren's disease.

Related Experiment Videos

Effect of corticosteroids on course of Guillain-Barré syndrome

Related Concept Videos

Related Articles